Spondylitis ankylopoetica (Bechterew-kór): vizsgálatok itt: Kanada
5 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleAn Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Study Participants With Active Juvenile Idiopathic Arthritis Subtypes Enthesitis-related Arthritis (Including Juvenile-onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis
- Where
- Calgary, Montreal, Saskatoon
- Életkor
- 2 év to 18 év
- People
- 40 worldwide
- Run by
- UCB Biopharma SRL
See details and how to joinNCT06668181 · EU 2023-508845-41-00 - 2. fázisTaking peopleA Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
- Where
- Québec, Toronto, Trois-Rivières
- Életkor
- 18 év to 80 év
- People
- 315 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07133633 · EU 2025-521059-21-00 - 1. fázisTaking peopleA Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
- Where
- Calgary, Vancouver
- Életkor
- 18 év and over
- People
- 20 worldwide
- Run by
- UCB Biopharma SRL
See details and how to joinNCT06888193 · EU 2024-518689-29-00 - No phaseTaking peopleExactech Shoulder Post Market Clinical Follow-up Study
- Where
- London
- Életkor
- 21 év and over
- People
- 20 000 worldwide
- Run by
- Exactech
See details and how to joinNCT05603728 - 4. fázisTaking peopleA Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis
- Where
- Ottawa, Québec
- Életkor
- 18 év and over
- People
- 100 worldwide
- Run by
- CARE ARTHRITIS LTD.
See details and how to joinNCT06454188 · EU 2023-510242-24-00